Profit

Luxembourg Stock Exchange to Delist Ranbaxy GDR Programme

 Share
EMAIL
PRINT
COMMENTS

New Delhi: Drug firm Ranbaxy Laboratories on Friday said Luxembourg Stock Exchange (LSE) will delist its GDR (global depository receipts) programme with effect from December 15.

In view of the proposed termination of the deposit agreement on December 15, 2014, the bourse will delist the GDS from the official list and withdraw the trading of GDS on the Euro MTF Market of the LSE with effect from December 15, 2014, Ranbaxy Laboratories Ltd said in a filing to the BSE.

The company said it has received a letter from LSE in this regard.

Earlier this month, the company had said that it has notified the Bank of New York Mellon to terminate the deposit agreements dated July 7, 1994 and underlying GDR programme.

Shares in Ranbaxy, on Friday, ended at Rs 632.10 apiece on the BSE, up 1.34 per cent from the previous close.



Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.

NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Top